Creating more effective drugs
Ascendis Pharma has raised €48M across 1 funding round from 2 investors, most recently a Series C round in Dec 2014. Based in Hellerup, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-12-01 | Series C | €48M |
| Sofinnova Partners,Venrock |
| View deal → |
